UNICA IRIS Institutional Research Information System

ONALI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 59.952
NA - Nord America 2.009
AS - Asia 291
SA - Sud America 7
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 62.265
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 59.517
US - Stati Uniti d'America 2.001
SE - Svezia 226
SG - Singapore 123
CN - Cina 92
FI - Finlandia 71
DE - Germania 62
VN - Vietnam 52
GB - Regno Unito 34
FR - Francia 7
HK - Hong Kong 7
BR - Brasile 6
CA - Canada 6
GR - Grecia 5
IE - Irlanda 5
IN - India 5
CZ - Repubblica Ceca 4
KR - Corea 4
AT - Austria 3
BD - Bangladesh 3
BE - Belgio 3
ES - Italia 3
HU - Ungheria 3
EU - Europa 2
MX - Messico 2
NL - Olanda 2
NZ - Nuova Zelanda 2
UA - Ucraina 2
AU - Australia 1
CH - Svizzera 1
CL - Cile 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
LU - Lussemburgo 1
MK - Macedonia 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 62.265
Salva come PNG Salva come JPEG
Città #
Cagliari 57.567
Uta 1.869
Ashburn 380
Fairfield 276
Nyköping 204
Boardman 154
Seattle 114
Wilmington 114
Chandler 105
Woodbridge 104
Cambridge 102
Houston 101
Helsinki 71
Singapore 64
Santa Clara 62
Dong Ket 52
Boston 49
New York 46
Redwood City 46
Ann Arbor 35
Rome 29
San Diego 20
London 16
Beijing 13
Shanghai 13
Jacksonville 9
Los Angeles 9
Mountain View 8
Nanjing 8
Hong Kong 7
Munich 7
Atlanta 5
Chattanooga 5
Jiaxing 5
Redmond 5
Stockholm 5
Brno 4
Dearborn 4
Kilburn 4
Norwalk 4
Piscataway 4
Seoul 4
Chiswick 3
Delhi 3
Florence 3
Garden City 3
Guangzhou 3
Milan 3
Patras 3
Vienna 3
Wuhan 3
Abergavenny 2
Acton 2
Anqing 2
Cedar Knolls 2
Churriana de la Vega 2
Cormano 2
Dalian 2
Falls Church 2
Fiesole 2
Frankfurt am Main 2
Isernia 2
Islington 2
Krefeld 2
Kunming 2
Merksem 2
Montecassiano 2
Montreal 2
Nanchang 2
Newark 2
Paris 2
Rende 2
Rockville 2
Sestu 2
Stony Brook 2
Szeged 2
Torino 2
Toronto 2
Ussana 2
Venice 2
Washington 2
Athens 1
Aubers 1
Auckland 1
Belgrade 1
Berkeley 1
Berlin 1
Borås 1
Bracke 1
Brussels 1
Changsha 1
Chizhou 1
Collegeville 1
Córdoba 1
Dhaka 1
Douglas 1
Dublin 1
Encino 1
Enola 1
Geislingen an der Steige 1
Totale 61.809
Salva come PNG Salva come JPEG
Nome #
IBD Flare in the COVID-19 Pandemic: Therapy Discontinuation Is to Blame 8.943
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab 1.967
An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors 1.953
Colonic phenotype of the ileum in Crohn's disease: A prospective study before and after ileocolonic resection 1.902
Ileal lesions in patients with ulcerative colitis after ileo-rectal anastomosis: Relationship with colonic metaplasia 1.772
Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease 1.529
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 1.508
Response Assessed by Ultrasonography as Target of Biological Treatment for Crohn's Disease 1.476
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 1.467
The Resolution of Intestinal Inflammation: The Peace-Keeper's Perspective 1.429
Steroid-free remission and closure of recto-vaginal fistula using adalimumab in a Crohn's disease patient naïve to anti-tumour necrosis factor alpha antibodies 1.416
Cancer and immunomodulators in inflammatory bowel diseases 1.295
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease 1.250
A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn's disease 1.241
Adalimumab in active ulcerative colitis: A "real-life" observational study 1.129
Small bowel capsule endoscopy vs conventional techniques in patients with symptoms highly compatible with Crohn's Disease 1.123
Psoriasis phenotype in inflammatory bowel disease: A case-control prospective study 1.106
Endoscopic vs ultrasonographic findings related to Crohn's Disease recurrence: A prospective longitudinal study at 3 years 1.084
Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis 1.057
Anti-TNF-alpha treatments and obstructive symptoms in Crohn's Disease: A prospective study 1.047
A novel Smad7 genetic variant mapping on the genomic region targeted by Mongersen is associated with Crohn's disease 979
The Italian clinical experience with adalimumab in Crohn's disease: Eleven clinical cases 977
Female reproductive health and inflammatory bowel disease: A practice-based review 937
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 930
Early post-operative endoscopic recurrence in Crohn's disease patients: Data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort 924
Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy 888
Tumor infiltrating regulatory t cells in sporadic and colitis-associated colorectal cancer: The red little riding hood and the wolf 885
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 838
Measuring disease activity in Crohn's disease 834
Post-operative recurrence of Crohn's disease: A prospective study at 5 years 804
GPR120/FFAR4: A Potential New Therapeutic Target for Inflammatory Bowel Disease 799
TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in Inflammatory bowel disease 789
Azathioprine for prevention of clinical recurrence in Crohn's disease patients with severe endoscopic recurrence: an IG-IBD randomized double-blind trial 785
Long-term safety of Infliximab for the treatment of inflammatory bowel disease: Does blocking TNFα reduce colitis-associated colorectal carcinogenesis? 767
Laparoscopic versus open ileo-colonic resection in crohn's disease: Short- and long-term results from a prospective longitudinal study 746
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 727
Efficacy and safety of infliximab and adalimumab in Crohn's disease: A single centre study 723
Cancer in Crohn's disease patients treated with infliximab: A long-term multicenter matched pair study 715
A Pharmacological Batch of Mongersen that Downregulates Smad7 is Effective as Induction Therapy in Active Crohn’s Disease: A Phase II, Open-Label Study 712
Comparative Effectiveness Research: A Roadmap to Sail the Seas of IBD Therapies 707
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 676
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 652
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 640
Development of a numerical index quantitating small bowel damage as detected by ultrasonography in Crohn's disease 631
A family study of asymptomatic small bowel Crohn's disease 628
Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: A single-center cohort study 596
Immune system and gut microbiota senescence in elderly IBD patients 592
Small intestine contrast ultrasonography vs computed tomography enteroclysis for assessing ileal Crohn's disease 580
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study 573
Wireless capsule endoscopy and proximal small bowel lesions in Crohn's disease 573
Frequency, pattern, and risk factors of postoperative recurrence of Crohn's disease after resection different from ileo-colonic 570
Accuracy of small-intestine contrast ultrasonography, compared with computed tomography enteroclysis, in characterizing lesions in patients with Crohn's disease 559
Frequency and pattern of endoscopic recurrence in Crohn's disease patients with ileocolonic resection using a laparoscopic versus laparotomic approach: A prospective longitudinal study 516
Non-invasive techniques for assessing postoperative recurrence in Crohn's disease 481
Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn's disease 454
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study 423
Severity of postoperative recurrence in Crohn's disease: Correlation between endoscopic and sonographic findings 414
Telemedicine in inflammatory bowel disease from its origin to the post pandemic golden age: A narrative review 307
Multiple Orocutaneous Extraintestinal Manifestations in Ulcerative Colitis Patient: Complete Response to Ustekinumab 304
Adherence to Mediterranean Diet and Diet Quality in Patients with Inflammatory Bowel Disease: A Single-Center, Observational, Case-Control Study 83
Suboptimal disease control and contributing factors in Italian IBD patients: The IBD-PODCAST Study 17
Italian validation of the IBD-disk tool for the assessment of disability in inflammatory bowel diseases: A cross-sectional multicenter study 4
Totale 62.433
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.068
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.068
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020501 0 0 0 0 0 204 124 32 41 35 20 45
2020/20213.250 60 82 83 639 831 313 107 248 78 120 126 563
2021/20225.351 220 367 306 237 377 498 188 351 646 570 934 657
2022/20238.657 544 1.071 1.175 529 725 1.276 454 733 461 543 738 408
2023/20247.747 399 352 293 492 633 1.533 953 824 395 528 635 710
2024/202536.691 15.737 12.943 4.281 2.011 927 792 0 0 0 0 0 0
Totale 62.433